PDE Inhibition and cognition enhancement

Author： Blokland Arjan   Menniti Frank S   Prickaerts Jos  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.4, 2012-04, pp. : 349-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE4 as a target for cognition enhancement

By Richter Wito  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 9, 2013-09 ,pp. : 1011-1027

Informa Healthcare

Access to resources Recommend Favorite

PDE4 inhibition in inflammatory lung disease

By  

Inpharma, Vol. 1, Iss. 1414, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Selective phosphodiesterase inhibitors: a promising target for cognition enhancement

By Reneerkens Olga   Rutten Kris   Steinbusch Harry   Blokland Arjan   Prickaerts Jos  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 419-443

Springer Publishing Company

Access to resources Recommend Favorite

Stereospecificity of myofibrillar calcium sensitivity and PDE inhibition in cardiotonic thiadiazinones

By Nadler G.   Delimoge I.   Lahouratate P.   Leger I.   Morvan M.   Zimmermann R.  

European Journal of Medicinal Chemistry, Vol. 31, Iss. 10, 1996-01 ,pp. : 805-812

Elsevier

Access to resources Recommend Favorite

Inhibition of Ca2+-calmodulin dependent phosphodiesterase (PDE1B1)

By Epstein P.M.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 109-112

Informa Healthcare

Access to resources Recommend Favorite